Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2016 1
2017 1
2019 4
2020 3
2021 3
2022 5
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Shmidt E, Faleck DM, Colombel JF. Shmidt E, et al. Among authors: faleck dm. Clin Gastroenterol Hepatol. 2022 Feb;20(2):469. doi: 10.1016/j.cgh.2021.04.010. Epub 2021 Apr 8. Clin Gastroenterol Hepatol. 2022. PMID: 33839279 No abstract available.
IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience.
Shirwaikar Thomas A, Lee SE, Shatila M, De Toni EN, Török HP, Ben Khaled N, Powell N, Weight R, Faleck DM, Wang Y. Shirwaikar Thomas A, et al. Among authors: faleck dm. Am J Gastroenterol. 2023 Sep 1;118(9):1679-1683. doi: 10.14309/ajg.0000000000002332. Epub 2023 Jun 22. Am J Gastroenterol. 2023. PMID: 37216614
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
Badran YR, Zou F, Durbin SM, Dutra BE, Abu-Sbeih H, Thomas AS, Altan M, Thompson JA, Qiao W, Leet DE, Lai PY, Horick NK, Postow MA, Faleck DM, Wang Y, Dougan M. Badran YR, et al. Among authors: faleck dm. J Immunother Cancer. 2023 Jun;11(6):e007195. doi: 10.1136/jitc-2023-007195. J Immunother Cancer. 2023. PMID: 37349130 Free PMC article.
Reply to Y. Inagaki et al.
Abu-Sbeih H, Faleck DM, Dougan M, Wang Y. Abu-Sbeih H, et al. Among authors: faleck dm. J Clin Oncol. 2020 May 20;38(15):1749-1750. doi: 10.1200/JCO.20.00295. Epub 2020 Apr 6. J Clin Oncol. 2020. PMID: 32250720 No abstract available.
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers.
Chatila WK, Walch H, Hechtman JF, Moyer SM, Sgambati V, Faleck DM, Srivastava A, Tang L, Benhamida J, Ismailgeci D, Campos C, Wu F, Chang Q, Vakiani E, de Stanchina E, Weiser MR, Widmar M, Yantiss RK, Shah MA, Bass AJ, Stadler ZK, Katz LH, Mellinghoff IK, Sethi NS, Schultz N, Ganesh K, Kelsen D, Yaeger R. Chatila WK, et al. Among authors: faleck dm. Nat Commun. 2023 Jan 7;14(1):110. doi: 10.1038/s41467-022-35592-9. Nat Commun. 2023. PMID: 36611031 Free PMC article.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P, Thummalapalli R, Betti MJ, Yao L, Quandt Z, Balaratnam K, Bejan CA, Cardenas E, Falcon CJ, Faleck DM; Princess Margaret Lung Group; Gubens MA, Huntsman S, Johnson DB, Kachuri L, Khan K, Li M, Lovly CM, Murray MH, Patel D, Werking K, Xu Y, Zhan LJ, Balko JM, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E. Middha P, et al. Among authors: faleck dm. medRxiv [Preprint]. 2023 Sep 13:2023.05.15.23289680. doi: 10.1101/2023.05.15.23289680. medRxiv. 2023. PMID: 37292751 Free PMC article. Updated. Preprint.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
Middha P, Thummalapalli R, Betti MJ, Yao L, Quandt Z, Balaratnam K, Bejan CA, Cardenas E, Falcon CJ, Faleck DM; Princess Margaret Lung Group; Gubens MA, Huntsman S, Johnson DB, Kachuri L, Khan K, Li M, Lovly CM, Murray MH, Patel D, Werking K, Xu Y, Zhan LJ, Balko JM, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E. Middha P, et al. Among authors: faleck dm. Nat Commun. 2024 Mar 26;15(1):2568. doi: 10.1038/s41467-023-44512-4. Nat Commun. 2024. PMID: 38531883 Free PMC article.
27 results